| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A Bβ 14 Arg → Cys fibrinogen variant in a patient with thrombotic complications (fibrinogen St-Germain III)
|
DE RAUCOURT, E.
|
|
2006
|
4 |
12 |
p. 2722-2723
|
artikel
|
| 2 |
Acute activation of the endothelium results in increased levels of active von Willebrand factor in hemolysis, elevated liver enzymes and low platelets (HELLP) syndrome
|
HULSTEIN, J. J. J.
|
|
2006
|
4 |
12 |
p. 2569-2575
|
artikel
|
| 3 |
Allosteric disulfide bonds in thrombosis and thrombolysis
|
CHEN, V. M.
|
|
2006
|
4 |
12 |
p. 2533-2541
|
artikel
|
| 4 |
ANNOUNCEMENTS
|
|
|
2006
|
4 |
12 |
p. 2745
|
artikel
|
| 5 |
A novel missense mutation responsible for factor VII deficiency in research Beagle colonies
|
CALLAN, M. B.
|
|
2006
|
4 |
12 |
p. 2616-2622
|
artikel
|
| 6 |
Bax activators potentiate coated-platelet formation
|
DALE, G. L.
|
|
2006
|
4 |
12 |
p. 2664-2669
|
artikel
|
| 7 |
CORRIGENDUM
|
|
|
2006
|
4 |
12 |
p. 2742
|
artikel
|
| 8 |
Diabetes mellitus and platelet function after administration of aspirin and a single 600 mg dose of clopidogrel
|
SIBBING, D.
|
|
2006
|
4 |
12 |
p. 2566-2568
|
artikel
|
| 9 |
Differential regulation of protein S expression in hepatocytes and sinusoidal endothelial cells in rats with cirrhosis
|
FUJII, K.
|
|
2006
|
4 |
12 |
p. 2607-2615
|
artikel
|
| 10 |
Distribution and dynamic changes of sphingolipids in blood in response to platelet activation
|
DAHM, F.
|
|
2006
|
4 |
12 |
p. 2704-2709
|
artikel
|
| 11 |
Early growth response transcription factor EGR-1 regulates Gαq gene in megakaryocytic cells
|
JALAGADUGULA, G.
|
|
2006
|
4 |
12 |
p. 2678-2686
|
artikel
|
| 12 |
Effect of pharmacologic plasminogen activator inhibitor-1 inhibition on cell motility and tumor angiogenesis
|
LEIK, C. E.
|
|
2006
|
4 |
12 |
p. 2710-2715
|
artikel
|
| 13 |
Estimation of a potentially preventable fraction of venous thromboembolism: a community-based prospective study
|
NOBOA, S.
|
|
2006
|
4 |
12 |
p. 2720-2722
|
artikel
|
| 14 |
Flow-based assays for global assessment of hemostasis. Part 2: current methods and considerations for the future 1
|
ZWAGINGA, J. J.
|
|
2006
|
4 |
12 |
p. 2716-2717
|
artikel
|
| 15 |
FORTHCOMING ARTICLES IN THE JANUARY ISSUE
|
|
|
2006
|
4 |
12 |
p. xiv
|
artikel
|
| 16 |
From γ-carboxy-glutamate to protein C
|
STENFLO, J.
|
|
2006
|
4 |
12 |
p. 2521-2526
|
artikel
|
| 17 |
Full evaluation of an acquired case of thrombotic thrombocytopenic purpura following the surgical resection of glioblastoma multiforme
|
CATALAND, S. R.
|
|
2006
|
4 |
12 |
p. 2733-2737
|
artikel
|
| 18 |
Incidence of inhibitors in a cohort of 838 males with hemophilia A previously treated with factor VIII concentrates
|
KEMPTON, C. L.
|
|
2006
|
4 |
12 |
p. 2576-2581
|
artikel
|
| 19 |
Inhibition of adhesive and signaling functions of the platelet GPIb-V-IX complex by a cell penetrating GPIbα peptide
|
DAVID, T.
|
|
2006
|
4 |
12 |
p. 2645-2655
|
artikel
|
| 20 |
Inhibition of tissue factor expression by hydroxyurea in polymorphonuclear leukocytes from patients with myeloproliferative disorders: a new effect for an old drug?
|
MAUGERI, N.
|
|
2006
|
4 |
12 |
p. 2593-2598
|
artikel
|
| 21 |
Low ankle–brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
|
AGNELLI, G.
|
|
2006
|
4 |
12 |
p. 2599-2606
|
artikel
|
| 22 |
More on: incorrect use of thromboprophylaxis for venous thromboembolism in medical and surgical patients: results of a multicentric, observational, and cross-sectional study in Brazil
|
LABARERE, J.
|
|
2006
|
4 |
12 |
p. 2737-2738
|
artikel
|
| 23 |
On the cutting edge: von Willebrand factor propeptide and thrombosis
|
RAGNI, M. V.
|
|
2006
|
4 |
12 |
p. 2553-2555
|
artikel
|
| 24 |
PAR-1 activation has different effects on the angiogenic activity of endothelial progenitor cells derived from human adult and cord blood
|
SMADJA, D. M.
|
|
2006
|
4 |
12 |
p. 2729-2731
|
artikel
|
| 25 |
PAR-1-dependent pp60src activation is dependent on protein kinase C and increased [Ca2+]i: evidence that pp60src does not regulate PAR-1-dependent Ca2+ entry in human platelets
|
HARPER, M. T.
|
|
2006
|
4 |
12 |
p. 2695-2703
|
artikel
|
| 26 |
Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study
|
LUTSEY, P. L.
|
|
2006
|
4 |
12 |
p. 2629-2635
|
artikel
|
| 27 |
Platelet activation and cardiovascular outcomes in acute coronary syndromes
|
BOOS, C. J.
|
|
2006
|
4 |
12 |
p. 2542-2543
|
artikel
|
| 28 |
Platelet function in patients with acute coronary syndrome (ACS) predicts recurrent ACS
|
FUCHS, I.
|
|
2006
|
4 |
12 |
p. 2547-2552
|
artikel
|
| 29 |
Platelet hyperactivity and risk of recurrent thrombosis
|
HARRISON, P.
|
|
2006
|
4 |
12 |
p. 2544-2546
|
artikel
|
| 30 |
Preconditioning ischemia attenuates molecular indices of platelet activation-aggregation
|
LINDEN, M. D.
|
|
2006
|
4 |
12 |
p. 2670-2677
|
artikel
|
| 31 |
Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C
|
GARDINER, C.
|
|
2006
|
4 |
12 |
p. 2724-2726
|
artikel
|
| 32 |
Prothrombin A19911G polymorphism and the risk of venous thromboembolism
|
MARTINELLI, I.
|
|
2006
|
4 |
12 |
p. 2582-2586
|
artikel
|
| 33 |
Prothrombotic factors enhance heparin-induced thrombocytopenia and thrombosis in vivo in a mouse model
|
REILLY, M. P.
|
|
2006
|
4 |
12 |
p. 2687-2694
|
artikel
|
| 34 |
Severe prothrombin deficiency caused by prothrombin-Edmonton (R-4Q) combined with a previously undetected deletion
|
WONG, A. Y. K.
|
|
2006
|
4 |
12 |
p. 2623-2628
|
artikel
|
| 35 |
Soluble CD40 ligand in asthma patients during allergen challenge
|
KOWAL, K.
|
|
2006
|
4 |
12 |
p. 2718-2720
|
artikel
|
| 36 |
Tackling the diabetic platelet: is high clopidogrel dosing the answer?
|
ANGIOLILLO, D. J.
|
|
2006
|
4 |
12 |
p. 2563-2565
|
artikel
|
| 37 |
TALKING ABOUT…
|
BRUTTOMESSO, G.
|
|
2006
|
4 |
12 |
p. 2739-2741
|
artikel
|
| 38 |
The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case–control study
|
CHINTHAMMITR, Y.
|
|
2006
|
4 |
12 |
p. 2587-2592
|
artikel
|
| 39 |
Thrombin-triggered platelet apoptosis
|
LEYTIN, V.
|
|
2006
|
4 |
12 |
p. 2656-2663
|
artikel
|
| 40 |
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: not yet
|
BAGLIN, T.
|
|
2006
|
4 |
12 |
p. 2530-2532
|
artikel
|
| 41 |
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis: yes
|
COSMI, B.
|
|
2006
|
4 |
12 |
p. 2527-2529
|
artikel
|
| 42 |
von Willebrand factor activates endothelial nitric oxide synthase in blood platelets by a glycoprotein Ib-dependent mechanism
|
RIBA, R.
|
|
2006
|
4 |
12 |
p. 2636-2644
|
artikel
|
| 43 |
von Willebrand factor and its propeptide: the influence of secretion and clearance on protein levels and the risk of venous thrombosis
|
NOSSENT, A. Y.
|
|
2006
|
4 |
12 |
p. 2556-2562
|
artikel
|
| 44 |
What causes the enhancement of activity of factor VIIa by tissue factor?
|
COLINA, C. M.
|
|
2006
|
4 |
12 |
p. 2726-2729
|
artikel
|
| 45 |
Who is at risk for occult cancer after venous thromboembolism?
|
BECKERS, M. M. J.
|
|
2006
|
4 |
12 |
p. 2731-2733
|
artikel
|
Tijdschrift beschrijving